Alfred W. Chung

Alfred W. Chung

Hematology Oncology
400 Parnassus Ave.
Fourth Floor
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

Journal: Cancer
Published: June 16, 2026

How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?

How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?

Journal: Immunotherapy
Published: October 17, 2025

Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.

Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.

Journal: bioRxiv : the preprint server for biology
Published: September 02, 2025

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.

Journal: Blood cancer journal
Published: June 06, 2025

Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.

Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.

Journal: Expert opinion on investigational drugs
Published: May 27, 2025

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.

Journal: Journal of clinical medicine
Published: May 14, 2025

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.

Journal: Blood
Published: August 01, 2024

BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.

BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.

Journal: Blood advances
Published: July 25, 2024

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Journal: Blood
Published: May 28, 2024

Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy.

Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy.

Journal: The American journal of medicine
Published: January 05, 2024

Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.

Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.

Journal: Blood advances
Published: November 06, 2023

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma.

Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma.

Journal: Leukemia & lymphoma
Published: August 21, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026